InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 35372

Tuesday, 05/31/2016 11:53:33 PM

Tuesday, May 31, 2016 11:53:33 PM

Post# of 48316
Good results from the combo p2b will lead to a phase 3 registration trial and designed for accelerated approval according to their latest investor pack. T-Vec trial was a phase 3 trial with nearly 300 people but if response rates are as good or better than T-Vec in a larger study with barely any side affects I think that Oncosec would deserve a much larger market cap than 30 million. Maybe this takes another 2 years but in the end this is heading in the right direction.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News